Private company
Apeiron Investment Group Ltd.
Last updated Oct 21, 2026.
Overview
- HeadquartersO11
Corporate structure
Apeiron Investment Group Ltd. sits at the top of its group. 7 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- Apeiron Investment Group Ltd. O1
- Atai Beckley N.V. Stake · P7
- AtaiBeckley Inc. Stake · New York, New York
- Enhanced Group Inc. Stake · Dallas, Texas, United States
- Faeth Therapeutics, Inc. Stake · Austin, Texas
- Neuphoria Therapeutics Inc. Stake · Burlington, Massachusetts
- Rezolve AI Stake · London, United Kingdom
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (6 companies). Each entity in the chart links to its source.
Stakes it holds
Apeiron Investment Group Ltd. has told the SEC it owns more than 5% of 6 companies, latest first (Schedules 13D and 13G).
- Enhanced Group Inc.SCHEDULE 13D/A May 14, 2026 to Sep 21, 20262
- AtaiBeckley Inc.SCHEDULE 13D/A Jul 17, 2026 to Sep 14, 20263
- Atai Beckley N.V.SCHEDULE 13D/A Feb 10, 2022 to Oct 20, 20254
- Neuphoria Therapeutics Inc.SCHEDULE 13D/A Dec 30, 2021 to Jan 28, 20255
- Rezolve AISC 13G Sep 30, 20246
- Faeth Therapeutics, Inc.SC 13D/A Feb 10, 2022 to Jun 2, 20237
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7